Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

This study has been terminated.
(Interim analysis of efficacy trial showed no drug efficacy.)
Sponsor:
Collaborator:
Collaborative Study Group (CSG)
Information provided by (Responsible Party):
Keryx Biopharmaceuticals
ClinicalTrials.gov Identifier:
NCT00462202
First received: April 16, 2007
Last updated: March 2, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 13, 2015